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Abstract
Experiments in isolated ventricular cardiomyocytes have greatly facilitated the
study of cellular and subcellular physiology in the heart. However, the isola-
tion and culture of high-quality adult murine ventricular cardiomyocytes can
be technically challenging. In most experimental protocols, the culture of
viable adult murine cardiomyocytes for prolonged time periods is achieved
with the addition of the myosin II ATPase inhibitors blebbistatin and/or 2,3-
butanedione monoxime (BDM). These drugs are added to increase cell viabil-
ity and life span by inhibiting spontaneous cardiomyocyte contraction, thereby
preventing calcium overload, cell hypercontracture, and cell death. While the
addition of BDM has been reported to prolong the life span of isolated adult
murine cardiomyocytes, it is also associated with several off-target effects.
Here, we report a novel off-target effect, in which BDM inhibits mitochon-
drial respiration by acting directly on the electron transport chain to reduce
cell viability. In contrast, when cells were cultured with blebbistatin alone, cells
survived for longer, and no metabolic off-target effects were observed. Based
on these novel observations, we recommend that culture media for isolated
mouse ventricular cardiomyocytes should be supplemented with blebbistatin
alone, as BDM has the potential to affect mitochondrial respiration and cell
viability, effects which may impact adversely on subsequent experiments.
Introduction
The ability to undertake experiments in isolated murine
ventricular cardiomyocytes have greatly facilitated the
study of cellular and subcellular physiology in the heart
(ranging from functional parameters such as ion channel
activity, calcium handling, and contractile function, to
signaling cascades and posttranslational modifications).
Cardiac-specific and inducible promoters have allowed
genetic knockout and knockin mice to be used to investi-
gate protein function specifically in the heart.
High-quality isolated ventricular cardiomyocytes are
required for these experimental studies to ensure that
reproducible and reliable data are obtained (reviewed in
Louch et al. 2011). While adult rat ventricular cardiomy-
ocytes are fairly robust and survive ex vivo for several
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days, the isolation of adult murine ventricular cardiomy-
ocytes is more challenging as the cells are more fragile
and the results of isolation are less consistent and sensi-
tive – the cell often undergoing rigor contracture and cell
death within 24 h of isolation. In order to prolong adult
murine ventricular cardiomyocyte viability, isolation buf-
fers and culture media are often supplemented with inhi-
bitors of myosin II ATPase such as 2,3-butanedione
monoxime (BDM) or blebbistatin (Kivisto et al. 1995;
Farman et al. 2008; Kabaeva et al. 2008). Although BDM
inhibits cardiac contraction, it also has multiple off-target
effects including altering L-type Ca2+ channel activity, SR
Ca2+ load (Gwathmey et al. 1991), and cardiac action
potential characteristics and conduction (Kettlewell et al.
2004; Lou et al. 2012). On the other hand, blebbistatin
has been reported to be more specific, with fewer off-tar-
get effects than BDM (Farman et al. 2008), with little
effect of cardiac action potential duration and characteris-
tics (Fedorov et al. 2007; Lou et al. 2012), L-type Ca2+
channel activity (Dou et al. 2007), or Ca2+ transient
propagation (Farman et al. 2008).
In the current study, we make the novel observation
that culturing isolated adult murine ventricular cardiomy-
ocytes with BDM also causes significant inhibition of
mitochondrial respiration, resulting in worse cell viability.
In contrast, culturing cells with blebbistatin prolonged cell
viability, with no effects on mitochondrial respiration.
Methods
Ethical statement
All experiments were performed according to Home
Office (UK) guidelines under the 1986 Animal (Scientific
Procedures) Act with University College London Ethics
Committee approval.
Isolation of adult murine ventricular
cardiomyocytes
Cardiomyocytes were isolated from C57/BL6 mice aged
between 8 and 10 weeks (Ibarra et al. 2013). Briefly, mice
were anesthetized using an intraperitoneal injection of
100 U pentobarbital and 30 U heparin. Hearts were
excised into ice-cold perfusion buffer and cannulated via
the aorta before retrograde perfusion on a modified Lan-
gendorff-system at 37°C. Perfusion buffer consisted of (in
mmol/L): NaCl 113, KCl 4.7, KH2PO4 0.6, Na2HPO4 0.6,
MgSO4-7H20 1.2, NaHCO3 12, KHCO3 10, Hepes Na salt
0.922, Taurine 30, BDM 10, Glucose 5.5, and was sterile
filtered prior to use. To clear the coronaries of residual
blood, hearts were perfused with the perfusion solution
for 5 min. Following this, the perfusate was switched to
digestion buffer for 20 min, which consisted of 30 mL
perfusion buffer containing 5 mg Liberase (Roche, UK)
and 12.5 lmol/L CaCl2. Digestion buffer was collected
and recirculated appropriately. After 20 min of perfusion
the heart had become enlarged, paler, and soft to touch.
The heart was gently removed from the cannula, and in
4 mL of digestion buffer it was teased apart, initially by
tweezers and then by gentle pipetting in a Pasteur pipette.
The heart cells were transferred into a new 15 mL Falcon
and the solution topped up to 10 mL with stop buffer 1
(1 mL FBS per 10 mL perfusion buffer). Cells were
allowed to pellet for 10 min, after which the supernatant
was removed and cells resuspended in increasing concen-
trations of Ca2+ (62 lmol/L, 212 lmol/L, and 1 mmol/
L). Cells were then resuspended in either M199 supple-
mented with L-carnitine (2 mmol/L), creatine (5 mmol/
L), taurine (5 mmol/L), and penicillin (100 IU/mL),
streptomycin (100 IU/mL) (for cell culture experiments)
or unbuffered DMEM supplemented with 4 mmol/L glu-
tamine, 5 mmol/L glucose, 200 lmol/L carnitine,
100 lmol/L Na pyruvate, 100 lmol/L BSA-palmatate and
10 mmol/L HEPES, pH 7.4 (for whole cell respiration
experiments) (Readnower et al. 2012).
Culture of isolated adult murine ventricular
cardiomyocytes
Cardiomyocytes were plated onto prelaminated six-well
plates suspended in M199 (Invitrogen, UK) media with
either no supplementation, or the addition of either
25 lmol/L blebbistatin, 9.9 lmol/L BDM (equivalent to
1 mg/mL), or both 25 lmol/L blebbistatin and 9.9 lmol/
L BDM. These concentrations of blebbistatin and BDM
have been typically used to prolong cardiomyocyte viabil-
ity for prolonged culture (Liao and Jain 2007; Kabaeva
et al. 2008; Louch et al. 2011; Readnower et al. 2012).
The media was changed after 2 h and images taken 2, 24,
and 48 h later. Where appropriate, cell death was assessed
through the addition of propidium iodide just prior to
imaging. Spontaneous contractions were quantified after
2 h postplating by video imaging for 1 min. The number
of spontaneous contractions in the set field of view were
counted and recorded. Equal cell density was assumed
between conditions and experimental replicates.
Measurement of whole cell respiration
Whole cell cardiomyocyte respiration was measured using
an Oxytherm (Hansatech, UK). Isolated cardiomyocytes
were resuspended in 600 lL unbuffered DMEM, which
was either unsupplemented or supplemented with 25
lmol/L blebbistatin, 9.9 lmol/L BDM, or both 25 lmol/L
blebbistatin and 9.9 lmol/L BDM. Basal respiration was
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established at 30°C, after which oligomycin (1 lg/mL),
FCCP (2 lmol/L), antimycin A (5 lmol/L), and rote-
none (2 lmol/L) were added. Respirometry was normal-
ized to cell protein concentration (samples were
sonicated and protein content assessed by Bradford
assay). For the Bradford assay, BSA protein standards
were prepared at the following concentrations (0, 0.4,
0.8, 1.2, 1.6, and 2 mg/mL) from a 2 mg/mL stock solu-
tion. Samples were diluted 1:10 in water and pipetted
out into a 96-well plate, before the addition of 200 lL
of bicinchoninic acid and copper(II) sulfate in a 50:1
ratio. Sample absorbance was read at 562 nm, and pro-
tein concentration calculated from the standard curve.
Oxygen consumption was expressed as nMol O2/min/mg
of cellular protein.
Isolation of murine cardiac mitochondria
Hearts were extracted into ice-cold CP1 buffer (KCl
100 mmol/L, MOPS 50 mmol/L, MgSO4 5 mmol/L,
EGTA 1 mmol/L, ATP 1 mmol/L, pH 7.4 with KOH).
The blood was removed by rinsing, tissue weighed, and
sliced before being homogenized in a dounce with a
teflon pestle (1 mL of CP1 buffer per 100 mg tissue).
After 16 strokes with the dounce, the homogenate was
transferred to an Eppendorff tube and incubated with
100 lL trypsin (stock concentration 5 mg/mL) per mL of
CP1 buffer for 10 min on ice. Homogenates were subse-
quently transferred to the dounce and combined with
equal volumes of CP2 (CP1 with 2 mg/mL fatty acid free
BSA) and homogenization completed by several further
dounce strokes. Samples were spun at 1000 g for 10 min
at 4°C, the supernatant transferred to fresh Eppendorffs
and respun at 5200 g for 10 min. The pellets were col-
lected and resuspended in CP2 buffer before being respun
at 5200 g for 10 min. Pellets were finally resuspended in
200 lL KME buffer (CP1 buffer minus the ATP) and
protein concentration quantified by Bradford assay.
Measurement of mitochondrial respiration
Mitochondrial respiration was assessed by measuring oxy-
gen consumption in an Oxytherm (Hansatech, UK) with a
magnetic stirrer at 25°C. After quantification of mitochon-
drial protein concentration, all mitochondrial samples
were normalized to a standard protein concentration of
5 lg/lL. Seventy lL of mitochondria (equivalent to
350 lL of mitochondrial protein) were added to 230 lL of
Miro 5 buffer (in mmol/L, EGTA 0.5, MgCl2.6H20 3, K-
lactobionate 60, Taruine 20, KH2PO4 10, HEPES 20,
Sucrose 110, fatty acid free BSA 1 g/L, pH 7.0 with KOH)
with 10 mmol/L glutamate, 10 mmol/L malate, 10 mmol/
L Na pyruvate to stimulate Complex I respiration (State 2
respiration). State 3 respiration was stimulated by the
addition of 0.5 mmol/L ADP, leak respiration through the
addition of 0.25 mmol/L oligomycin, and maximal uncou-
pled respiration with sequential additions of 2 lmol/L
FCCP. Finally, 5 lmol/L antimycin A was added to inhibit
all respiration and assess nonmitochondrial loss of O2
from the chamber. Oxygen consumption was expressed as
nMol O2/min/mg of mitochondrial protein.
Statistical analysis
Results were analyzed using an unpaired t-test or an one-
way analysis of variance followed by a Tukey’s posttest
where appropriate. Statistical significance was achieved
when P < 0.05.
Results
Effects of blebbistatin and BDM
supplementation on cardiomyocyte viability
As expected blebbistatin and/or BDM supplementation
significantly inhibited spontaneous cardiomyocyte con-
traction (Fig. 1A). Control isolated adult murine ventric-
ular cardiomyocytes cultured in the absence of
blebbistatin or BDM underwent hypercontracture and cell
death within 24 h after plating (Fig. 1B and C). (Sponta-
neous contractions were counted as cells which returned
immediately to their original length, while under hyper-
contracture, myocytes failed to return to their original
morphology). However, those cells which were supple-
mented with blebbistatin had better cell viability at all
time points up to and including 48 h following plating
(blebbistatin – 32  6.6% cell death vs. Control
98  0.4% cell death after 48 h). Although culturing with
BDM alone significantly reduced spontaneous contrac-
tions, cell viability was not significantly improved after
6 h when compared to control (BDM – 18.8  1.2% cell
death vs. Control 30.9  6.9% cell death), but by 18 h it
increased cell death when compared to control (BDM –
99.7  0.2% cell death vs. Control 63.7  6.6% cell
death) (Fig. 1B and C), suggesting a detrimental effect
with BDM on cell viability. Culturing with both BDM
and blebbistatin blunted the beneficial effect on cellular
viability observed with blebbistatin alone at 6 h and sub-
sequent time points (Fig. 1B and C).
BDM inhibits cellular respiration
In order to investigate the potential mechanisms underly-
ing the detrimental effects of BDM supplementation on
cell viability, we investigated the effect of BDM and/or
blebbistatin on cellular respiration (Fig. 2A–D). Following
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Figure 1. Viability of isolated mouse ventricular myocytes in M199 culture media unsupplemented or supplemented BDM with blebbistatin or
BDM and blebbistatin. (A) The frequency of spontaneous contractions measured per minute immediately after plating is significantly reduced by
culture with blebbistatin, BDM, or blebbistatin and BDM in combination. *versus control P < 0.05. (B) The time course of cell viability of
isolated ventricular mouse myocytes in culture at 2, 24, and 48 h postplating (representative images). Supplementation with blebbistatin alone
maintains cell viability to a greater extent that culture with BDM, blebbistatin and BDM in combination, or without any supplementation at
both 24 and 48 h. (C) Viability of myocytes assessed by PI staining at 6, 18, 24, and 48 h after plating. Supplementation with blebbistatin
keeps a greater proportion of isolated mouse myocytes alive throughout the 48 h post isolation. *versus control P < 0.05.
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a period of stabilization, the addition of oligomycin, to
inhibit ATP synthase (for the assessment of mitochondrial
respiration leak) had no effect on mitochondrial respira-
tion rate indicating that either the oligomycin was ineffec-
tive and unable to enter the mitochondria to inhibit the
ATP synthase, or that the initial respiration measured was
indeed independent of the ATP synthase, and thus due to
electron leak through the mitochondrial respiratory com-
plexes. It has been suggested that the inability of oligomy-
cin to reduce mitochondrial oxygen consumption is due
to the quiescence of the cells. When the cells are not con-
tracting, the energy demands low enough to be met by
glycolysis (which is independent of the mitochondria),
and thus oligomycin inhibits an ATP synthase which is
already inactive (Readnower et al. 2012).
To investigate the mitochondrial respiratory reserve of
isolated cells, the H+ ionophore, FCCP, was added sequen-
tially through repeated drug additions, until maximal
respiration was stimulated. In both control and blebbis-
tatin -treated cells, FCCP increased oxygen consumption
to a similar extent, indicating that the mitochondria were
able to respire and meet the increased demand for electron
transfer. However, in cells treated with BDM alone, or
BDM and blebbistatin in combination, FCCP had no
effect, indicating that mitochondrial respiration was inhib-
ited by BDM.
Antimycin A (an inhibitor of Complex III) inhibited
mitochondrial respiration in both the control and blebbis-
tatin -treated samples, indicating that electrons were able to
flow through the electron transport chain (ETC.) in these
samples. In the samples treated with BDM alone, and BDM
and blebbistatin in combination, antimycin A had little
effect, indicating that mitochondrial respiration was already
inhibited at some point along the ETC. by BDM.
BDM directly inhibits mitochondrial
respiration
To investigate whether the inhibitory effect of BDM sup-
plementation on cellular respiration was a direct effect on
Figure 2. Whole cell respiration is significantly impaired in isolated adult murine ventricular cardiomyocytes when supplemented with BDM.
Myocytes were either untreated or treated with blebbistatin or BDM or blebbistatin and BDM in combination prior to respiration measurements
in the Oxytherm Chamber. The addition of oligomycin was used to assess leak respiration, FCCP to assess maximal respiration, and antimycin
A/rotenone used to inhibit all mitochondrial oxygen consumption. Representative trace demonstrating that oxygen consumption was (A)
unaffected in cells cultured with supplementary blebbistatin, (B) significantly impaired in cells cultured with supplementary BDM, and (C)
significantly impaired in cells cultured with supplementary BDM and blebbistatin in combination. (D) Maximal oxygen consumption stimulated
by FCCP was significantly decreased in cells cultured with supplementary BDM alone or with blebbistatin and BDM in combination, when
compared to cells which were supplemented with blebbistatin alone or control. Values were calculated by dividing the maximal rate of FCCP-
stimulated oxygen consumption by the amount of myocytes protein contained in the chamber. *versus control P < 0.05.
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mitochondrial respiratory function, oxygen consumption
was measured in isolated cardiac mitochondria in the
presence of blebbistatin and/or BDM.
The addition of blebbistatin had no effect on mito-
chondrial respiration when compared to control (Fig. 3).
Under these conditions, mitochondrial respiration was
stimulated by both coupled (ADP) and uncoupled
(FCCP) agonists, and to the same degree. However, mito-
chondria treated with BDM alone or BDM and blebbis-
tatin in combination were unable to increase their
respiratory rate in response to either ADP or FCCP, indi-
cating that respiration was again inhibited to a basal leak
level. The inhibition of mitochondrial respiration by
BDM was especially striking when comparing the respira-
tory control ratios (RCR, initial Complex I respiration/
ADP-stimulated respiration). RCR values for healthy
mitochondria are expected to be between 6 and 8 (Silva
and Oliveira 2012), which are observed for both the con-
trol (6.3  0.4) and blebbistatin -treated (5.9  0.6)
mitochondria. However, the mitochondria treated with
Figure 3. Mitochondrial respiration is significantly impaired by supplementing with BDM. Respiration was measured in isolated cardiac
mitochondria either untreated or treated with blebbistatin or BDM or blebbistatin and BDM in combination. Coupled respiration was assessed
through the addition of ADP and leak respiration through the addition of oligomycin. Maximal respiration was measured through the addition
of FCCP before mitochondrial respiration was inhibited through the addition of antimycin A. Representative trace demonstrating that
mitochondrial respiration is (A) unaffected by treatment with blebbistatin, (B) significantly impaired by the addition of BDM, and (C) significantly
impaired by treatment with both blebbistatin and BDM. (D) ADP-stimulated (coupled) respiration is significantly inhibited when mitochondria
are incubated with BDM alone or BDM and blebbistatin in combination (*P > 0.05 vs. control, one-way ANOVA with Tukey’s posttest).
Treatment with blebbistatin alone had no effect on ADP-stimulated (coupled) respiration. (E) Treated with either BDM or blebbistatin and BDM
in combination, significantly reduced the maximal oxygen consumption stimulated by FCCP, compared to control mitochondria (*P > 0.05 vs.
control, one-way ANOVA with Tukey’s posttest). Treatment with blebbistatin alone did not alter mitochondrial maximal respiratory capacity,
being similar to control. (F) Respiration control ratios (ADP-independent respiration/ADP-dependent respiration) were significantly lower in
mitochondria treated with BDM alone or both BDM and blebbistatin in combination (*P < 0.05 vs. control, one-way ANOVA with Tukey’s
posttest). Treatment with blebbistatin alone did not alter the respiration control ratios, being similar to control.
2016 | Vol. 4 | Iss. 1 | e12606
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BDM alone or BDM and blebbistatin in combination only
achieved RCRs of 2.4 (0.4) and 1.9 (0.6), indicating
highly uncoupled and dysfunctional mitochondria. A sim-
ilar trend was observed when maximal respiration was
stimulated with the addition of FCCP. FCCP stimulated a
large increase, and maximal respiration in both the con-
trol and blebbistatin -treated mitochondria. In mitochon-
dria treated with BDM alone or BDM and blebbistatin in
combination, FCCP-stimulated mitochondrial respiration
was significantly lower, indicating a direct inhibitory
effect of BDM on the mitochondria.
Discussion
The main findings of this study are as follows: (1) supple-
mentation with blebbistatin prolonged the viability of iso-
lated adult murine ventricular cardiomyocytes without
affecting mitochondrial respiration; (2) supplementation
with BDM was detrimental to both cellular viability and
mitochondrial respiration.
In the results presented here, we show that culturing
cells with blebbistatin significantly improves cell viability
in terms of both number and duration. This is important
since a range of experiments are conducted over long
time periods (such as viral transfections), and require a
large number of healthy cells (western blots etc.). Similar
results were reported by Kabeva et al., who also reported
that blebbistatin, as the more specific myosin II ATPase
inhibitor, is superior to BDM as a culture supplement in
terms of both cell viability, and transfection efficiency
(Kabaeva et al. 2008).
BDM has been reported to have several off-target
effects, including altered L-type Ca2+ channel activity, SR
Ca2+ load (Gwathmey et al. 1991) and action potential
characteristics and conduction velocity (Kettlewell et al.
2004; Lou et al. 2012). In the current study, we report
that BDM also acts as a potent inhibitor of mitochondrial
respiration. This, in part, may explain why cell viability is
reduced when supplemented with BDM. While the exact
mechanism of the inhibitory effect is beyond the scope of
this study, our data have demonstrated that this effect is
a direct effect on mitochondrial respiration, possibly at
the level of the electron transport chain. Our observation
made in mouse cardiac mitochondria and cardiac myo-
cytes is in agreement with other studies performed on rat
and guinea pig hearts, which also report that BDM inhi-
bits mitochondrial respiration at Complex I (Hebisch
et al. 1993; Scaduto and Grotyohann 2000). This is an
important consideration since cardioprotective drug tar-
gets may reside in the mitochondria (Walters et al. 2012;
Hernandez-Resendiz et al. 2013). If the basic physiological
function of the mitochondria is inhibited, the effect of
the drug and pathways will be altered, leading to conflict-
ing and misleading results. While we report a detrimental
effect upon survival, others report that BDM is able to
protect the heart against cardiac ischemia–reperfusion
(Garcia-Dorado et al. 1992). However, a common mecha-
nism (metabolic inhibition) can explain these apparent
contradictory outcomes. Recent studies suggest that mito-
chondrial metabolism in the absence of oxygen leads to
an accumulation of succinate, and upon reperfusion, this
generates reactive oxygen species, which are the main
source of damage to the heart (Chouchani et al. 2014).
An earlier study from the same group (Chouchani et al.
2013) shows that reversible inhibition of Complex I
through the addition of MitoSNO upon reperfusion is
protective. By inhibiting Complex I, the pathway through
which electrons from succinate flow in reverse (reverse
electron transfer) to Complex I to generate ROS, is inhib-
ited, protecting the heart. Thus, the inhibition of mito-
chondrial metabolism (through Complex I inhibition;
Scaduto and Grotyohann 2000) with BDM during ische-
mia, and into reperfusion, may work through a similar
mechanism. With BDM inhibiting mitochondrial respira-
tion, the burst of reactive oxygen species upon reperfu-
sion will be dampened, protecting the heart against I-R
damage. Importantly, we advocate that culture of mouse
cardiac myocytes with BDM is detrimental.
Notably, we have found that blebbistatin increased cell
viability without having any effect on mitochondrial res-
piration. Blebbistatin has also been reported to not affect
many other important cardiac characteristics, such as the
cardiac action potential (Fedorov et al. 2007; Lou et al.
2012), L-type Ca2+ channel activity (Dou et al. 2007), or
Ca2+ transient propagation (Farman et al. 2008). It is
worth noting that an interaction between blebbistatin and
Fluo-4 has been reported, which prohibits the use of this
Ca2+ indicator (Farman et al. 2008).
In summary, when culturing isolated adult murine ven-
tricular cardiomyocytes supplementation with blebbistatin
is more effective at prolonging cell viability than BDM.
Furthermore, we show for the first time that BDM inhi-
bits mitochondrial respiration and adversely affects cell
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